Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Huison Pharmaceutical is a leading Chinese pharmaceutical company specializing in the research, development, and large-scale production of natural botanical extracts and traditional Chinese medicines. Founded in 1998 and headquartered in Hangzhou, the company is recognized as one of the world's largest producers of standardized Ginkgo biloba extract. Huison operates as a key subsidiary of Zhejiang Conba Pharmaceutical, utilizing state-of-the-art GMP-certified facilities to provide high-quality APIs and finished dosage forms to the global pharmaceutical and nutraceutical industries. Their expertise spans the entire supply chain, from GAP-compliant cultivation to advanced extraction technologies and international regulatory compliance. The company's product portfolio primarily targets cardiovascular health, cognitive function, and metabolic wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Huison Pharmaceutical.